mja.com.au | The Medical Journal of Australia

Home | Issues | MJA shop | MJA Careers | Contact | Topics | Search | RSS  | Login | Buy full access

Letters

Is Australia headed for an epidemic of nicotine replacement therapy addicts?

Christine L Paul, Flora Tzelepis, Raoul A Walsh and Billie Bonevski
MJA 2008; 189 (6): 346

To the Editor: Growing revenue from the sale of products for nicotine-replacement therapy (NRT), such as nicotine patches, has fuelled media interest in the likelihood that “reformed smokers” are “getting hooked on nicotine replacement”.1 While there may be anecdotal evidence of long-term use, there are no current population-based data to indicate whether this is the case in Australia.

Overseas data suggest long-term use of NRT is low.2,3 For example, a United States study found the median duration of patch use decreased from 30 days to 21 days following over-the-counter NRT availability.2 Another study found that more than 75% of NRT purchases were for 1 month, while only 5% of smokers purchased NRT for more than 3 consecutive months and less than 1% of purchases continued to 24 months.3 An Australian survey conducted in 2000 suggested that most NRT use (61%) was short-term, lasting less than 2 weeks.4

More recently, our 2004 telephone survey of smoking-related perceptions and practices included an item on length of NRT use. The survey involved households selected at random from the New South Wales electronic white pages, with quotas applied to the sample based on NSW census proportions. The study was approved by the University of Newcastle Human Research Ethics Committee.

Of the 3503 participants (response rate, 43%), all 539 current smokers and 1013 former smokers were asked about NRT use. Those who had made their most recent quit attempt in the previous 2 years reported on their NRT use during that quit attempt. Of the 138 who had used NRT on their most recent quit attempt, only three (2%) used an NRT product for 12 weeks (the recommended length of use). Only four NRT users (3%) reported using the product for more than 3 months, and none reported using NRT for more than 6 months.

It appears that fears of widespread addiction to NRT products are probably unfounded. In fact, lack of compliance with use recommendations, resulting in inappropriately short episodes of use, is probably a bigger problem, and one that may help explain the disappointing effectiveness of NRT under “real world” over-the-counter conditions.5 Data on frequent repeated short-term use of NRT products would be useful to round out the picture on NRT use in the over-the-counter environment.

Acknowledgements: This letter was prepared by the Centre for Health Research & Psycho-oncology (CHeRP). CHeRP is funded by the Cancer Council NSW and the University of Newcastle, and receives infrastructure support from the Hunter Medical Research Institute. We acknowledge the statistical support of Mr Christophe Lecathelinais and the time contribution of the study participants.

Christine L Paul, Senior Research AcademicFlora Tzelepis, Senior Research OfficerRaoul A Walsh, Senior Research AcademicBillie Bonevski, Senior Research Academic

Centre for Health Research & Psycho-oncology (CHeRP), Cancer Council NSW and University of Newcastle, Newcastle, NSW.

chris.paulATnewcastle.edu.au

  1. Harrison D. Ciggy substitute abuse on rise. Sydney Morning Herald 2008; 30 Mar. http://www.smh.com.au/news/national/ciggy-substitute-abuse-on-rise/2008/03/29/1206207492941.html (accessed Jul 2008).
  2. Hyland A, Rezaishiraz H, Giovion G, et al. Over-the-counter availability of nicotine replacement therapy and smoking cessation. Nicotine Tob Res 2005; 7: 547-555. <PubMed>
  3. Shiffman S, Hughes JR, Pillitteri JL, Burton SL. Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample. Tob Control 2003; 12: 310-316. <PubMed>
  4. Paul CL, Walsh RA, Girgis A. Nicotine replacement therapy products over-the-counter: real-life use in the Australian community. Aust N Z J Public Health 2003; 27: 491-495. <PubMed>
  5. Walsh RA. Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness. Drug Alcohol Rev 2008; 27: 200-203. <PubMed>

(Received 23 Apr 2008, accepted 29 May 2008)


Home | Issues | MJA shop | Terms of use | MJA Careers | More... | Contact | Topics | Search | RSS 

mja.com.au | The Medical Journal of Australia  

©The Medical Journal of Australia 2008 www.mja.com.au PRINT ISSN: 0025-729X ONLINE ISSN: 1326-5377